Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Norihito Soga
Risk Factors Contributing to the Development of Hypocalcemia After Zoledronic Acid Administration in Patients With Bone Metastases of Solid Tumor
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Related publications
Zoledronic Acid and Skeletal Complications in Patients With Solid Tumors and Bone Metastases
Cancer
Cancer Research
Oncology
Risk Factors for Development of Hypocalcemia in Patients With Cancer Treated With Bone-Modifying Agents
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
High Serum ALP Level Is Associated With Increased Risk of Denosumab-Related Hypocalcemia in Patients With Bone Metastases From Solid Tumors
Endocrine Journal
Endocrinology
Metabolism
Diabetes
Economic Evaluation of Denosumab Compared With Zoledronic Acid in Hormone-Refractory Prostate Cancer Patients With Bone Metastases
Journal of Managed Care Pharmacy
Risk Factors for Severe Hypocalcemia After Parathyroidectomy in Dialysis Patients With Secondary Hyperparathyroidism
Scientific Reports
Multidisciplinary
Effects of Zoledronic Acid on Bone Fusion in Osteoporotic Patients After Lumbar Fusion
Osteoporosis International
Medicine
Endocrinology
Metabolism
Diabetes
Indirect Evaluation of Bone Saturation With Zoledronic Acid After Long‐Term Dosing
Oncologist
Cancer Research
Medicine
Oncology
Cost-Effectiveness of Regular Utilization of Zoledronic Acid for Developed Bone Metastases From Advanced Breast Cancer in Chinese Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Incidence and Risk Factors of Osteonecrosis of the Jaw in Advanced Cancer Patients After Treatment With Zoledronic Acid or Denosumab: A Retrospective Cohort Study
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
